Business

Johnson & Johnson takes lead in COVID-19 cure
Business

Johnson & Johnson takes lead in COVID-19 cure

The drug company, Johnson & Johnson recently announced that it had made progress on a vaccine to prevent COVID-19 and that the product could be ready in early 2021. The New Brunswick, N.J., company selected a lead candidate for the vaccine from the constructs it had been working on, and said human trials would begin…

PPMA offers conditional support to deal with coronavirus outbreak
Business

PPMA offers conditional support to deal with coronavirus outbreak

KARACHI: The Pakistan Pharmaceutical Manufacturers Association (PPMA) is ready for an uninterrupted supply of life-saving drugs to deal with the coronavirus outbreak in Pakistan if the federal government fixed the dollar’s exchange rate at Rs155 and ensures costume clearance of raw-material consignment at ports round the clock. The pharmaceutical industry of Pakistan has said that…

COVID-19 Fund launched by WHO and partners
Business

COVID-19 Fund launched by WHO and partners

WASHINGTON: A new coronavirus disease (COVID-19) Solidarity Response Fund will raise money from a wide range of donors to support the work of the World Health Organization (WHO) and partners to help countries respond to the COVID-19 pandemic. The fund, the first-of-its-kind, enables private individuals, corporations, and institutions anywhere in the world to come together…

LHC stays the purchase of Insulin in public hospitals
Business

LHC stays the purchase of Insulin in public hospitals

LAHORE: The Lahore High Court (LHC) recently issued a stay on a petition by the Getz Pharmaceutical Company, challenging the change of conditions for the tender after shortlisting process. The order passed by Justice Ayesha A. Malik restrained the Punjab government from proceeding further on a purchase order for supply of insulin to public hospitals…

GSK’s drug accepted for accelerated assessment by the EMA
Business

GSK’s drug accepted for accelerated assessment by the EMA

LONDON: GlaxoSmithKline pharmaceutical company recently announced that the European Medicines Agency (EMA) validated the marketing authorisation application (MAA) for belantamab mafodotin. The drug could be used for the treatment of patients with relapsed or refractory multiple myeloma whose prior therapy included an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody. Belantamab mafodotin was accepted…

Artificial Intelligence sent the First Warnings of the Wuhan Virus
Business

Artificial Intelligence sent the First Warnings of the Wuhan Virus

Canada: The World Health Organization recently notified the public of a flu-like outbreak in China: a cluster of pneumonia cases had been reported in Wuhan, possibly from vendors’ exposure to live animals at the Huanan Seafood Market. BlueDot uses an AI-driven algorithm that scoured foreign-language news reports, animal and plant disease networks, and official proclamations to give…

AKU and PBS collab with Lilly to facilitate cancer patients
Business

AKU and PBS collab with Lilly to facilitate cancer patients

KARACHI: The Aga Khan University Hospital (AKUH) and the Patients Behbud Society for AKUH (PBS) recently announced their partnership with Eli Lilly Pakistan Pvt. Ltd. (Lilly) to provide access to targeted therapy treatment of cancer patients with limited financial means. Ms Shagufta Hassan, Chief Executive Officer, AKUH, Ammad Siddiqui, GM, Lilly, and Nadeem Mustafa Khan,…

ADB Supported UNICEF to strengthen immunization program
Business

ADB Supported UNICEF to strengthen immunization program

MANILA: The United Nations Children’s Fund (UNICEF) and the Government of Samoa recently signed a grant agreement to provide support to the health sector. The agreement would help to strengthen the country’s immunization program and procure cold chain equipment to safely transport vaccines. The program was supported by the Asian Development Bank (ADB) through the…

Cu 64 dotatate injection: FDA Filing of drug in process
Business

Cu 64 dotatate injection: FDA Filing of drug in process

Houston and St Louis: RadioMedix Inc and its commercial partner, Curium, recently announced that the New Drug Application for copper Cu 64 dotatate injection was filed with the U.S. Food and Drug Administration (FDA). The copper Cu 64 dotatate injection is a PET diagnostic agent intended for somatostatin receptor (SSTR) expressing neuroendocrine tumors (NETs). The…

1 2 3 6

Medical News is the only periodical in Pakistan which has 3 simultaneous editions from Karachi, Islamabad and online.

Latest E-Paper
Like Us On Facebook
For Subscription